Genpact (NYSE:G) Price Target Cut to $41.00 by Analysts at Jefferies Financial Group

Genpact (NYSE:G – Get Rating) had its target price cut by Jefferies Financial Group from $47.00 to $41.00 in a research note published on Monday morning, The Fly reports.

G has been the topic of several other research reports. Robert W. Baird decreased their price target on shares of Genpact from $54.00 to $48.00 in a report on Thursday, May 11th. BMO Capital Markets boosted their price target on shares of Genpact from $51.00 to $53.00 and gave the stock a market perform rating in a research note on Wednesday, February 8th. Citigroup dropped their price objective on Genpact from $54.00 to $46.00 in a research note on Thursday, May 11th. StockNews.com downgraded shares of Genpact from a strong-buy rating to a buy rating in a research note on Friday, April 28th. Finally, Needham & Company LLC reissued a buy rating and set a $56.00 price target on shares of Genpact in a research report on Friday, February 10th. Two investment analysts have rated the stock with a hold rating and three have issued a buy rating to the company. According to data from MarketBeat.com, the company presently has an average rating of Moderate Buy and an average target price of $49.00.

Genpact Trading Up 0.3 %

NYSE G opened at $36.97 on Monday. The company has a current ratio of 1.61, a quick ratio of 1.61 and a debt-to-equity ratio of 0.68. The business has a fifty day simple moving average of $43.86 and a 200 day simple moving average of $45.49. Genpact has a 12 month low of $35.75 and a 12 month high of $48.85. The firm has a market capitalization of $6.81 billion, a P/E ratio of 19.06, a PEG ratio of 1.67 and a beta of 1.20.

Genpact Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Monday, June 26th. Stockholders of record on Friday, June 9th will be paid a dividend of $0.1375 per share. This represents a $0.55 dividend on an annualized basis and a dividend yield of 1.49%. The ex-dividend date is Thursday, June 8th. Genpact’s payout ratio is 28.35%.

Insider Buying and Selling

In related news, SVP Heather White sold 12,500 shares of Genpact stock in a transaction that occurred on Friday, May 5th. The stock was sold at an average price of $40.72, for a total transaction of $509,000.00. Following the sale, the senior vice president now directly owns 40,845 shares in the company, valued at $1,663,208.40. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. In other news, SVP Heather White sold 12,500 shares of the business’s stock in a transaction that occurred on Friday, May 5th. The stock was sold at an average price of $40.72, for a total value of $509,000.00. Following the sale, the senior vice president now directly owns 40,845 shares of the company’s stock, valued at approximately $1,663,208.40. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, CEO N. V. Tyagarajan sold 50,000 shares of the company’s stock in a transaction that occurred on Thursday, May 4th. The stock was sold at an average price of $41.23, for a total value of $2,061,500.00. Following the completion of the sale, the chief executive officer now owns 805,509 shares in the company, valued at approximately $33,211,136.07. The disclosure for this sale can be found here. Insiders sold a total of 320,500 shares of company stock valued at $14,299,320 over the last three months. Corporate insiders own 2.62% of the company’s stock.

Hedge Funds Weigh In On Genpact

A number of hedge funds have recently bought and sold shares of the company. Ronald Blue Trust Inc. bought a new position in Genpact during the fourth quarter valued at approximately $28,000. Exchange Traded Concepts LLC purchased a new stake in Genpact during the 4th quarter valued at $30,000. Fred Alger Management LLC lifted its holdings in shares of Genpact by 136.7% during the 4th quarter. Fred Alger Management LLC now owns 878 shares of the business services provider’s stock valued at $41,000 after buying an additional 507 shares during the period. Cullen Frost Bankers Inc. purchased a new position in shares of Genpact in the 3rd quarter worth $39,000. Finally, Clearstead Advisors LLC bought a new stake in shares of Genpact in the first quarter worth $42,000. Institutional investors own 95.17% of the company’s stock.

Genpact Company Profile

(Get Rating)

Genpact Ltd. engages in the business process management, outsourcing, shared services and information outsourcing. The company operates through the following segments: Banking, Capital Markets and Insurance (BCMI), Consumer Goods, Retail, Life Sciences, and Healthcare (CGRLH) and High Tech, Manufacturing, and Services (HMS).